Home

Mankind Pharma Ltd EPS

Image

Mankind Pharma Ltd

NSE: MANKIND

EPS

₹ 48.13

Last updated on: Jul 02, 2025

Key Highlights

  • The Earning per Share of Mankind Pharma Ltd is ₹ 48.13 as of 02 Jul 25 .
  • The earning per share of Mankind Pharma Ltd changed from ₹ 12.15 to ₹ 10.19 over 8 quarters. This represents a CAGR of -8.42% .

Historical Earning per Share of Mankind Pharma Ltd

No data available

* All values are in

Company Fundamentals for Mankind Pharma Ltd

Market Cap

98,491 Cr

EPS

48.1

P/E Ratio (TTM)

49.6

P/B Ratio (TTM)

6.9

Day’s High

2394.25

Day’s Low

2355.0

DTE

0.6

ROE

13.9

52 Week High

3050.0

52 Week Low

1910.1

ROCE

12.9

Market Price of Mankind Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Mankind Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Jul 20252386.35
01 Jul 20252288.8
30 Jun 20252322.8
27 Jun 20252334.25
26 Jun 20252302.65
25 Jun 20252309
24 Jun 20252308.2
23 Jun 20252299.5
20 Jun 20252289.05
19 Jun 20252322.75

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Mankind Pharma Ltd

Asset Value vs Market Value of Mankind Pharma Ltd

Market Value

98,492

Asset Value

Value addition

19.7 X

4,765

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Mankind Pharma Ltd98491
Sun Pharmaceutical Industries Ltd402584
Divis Laboratories Ltd182147
Cipla Ltd120934
Torrent Pharmaceuticals Ltd113320
Dr Reddys Laboratories Ltd106138

Historical Market Cap of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Mankind Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Mankind Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Mankind Pharma Ltd News Hub

Mankind Pharma allots 9000 equity shares under ESOP

Mankind Pharma has allotted 9000 equity shares under ESOP on 14 August 2024. Consequent to the afore

Read more

14 Aug 24

Mankind Pharma Ltd gains for fifth session

Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2150.3, u

Read more

12 Aug 24

Mankind Pharma Ltd soars 1.03%

Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2079.3, u

Read more

08 Aug 24

Mankind Pharma to transfer its OTC business to Mankind Consumer Products

Mankind Pharma has executed the Business Transfer Agreement (BTA) on 03 September 2024 to transfer O

Read more

03 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

PPT

Jan 2024

PPT

June 2023

TranscriptPPT

FAQs for EPS of Mankind Pharma Ltd

What is the EPS of Mankind Pharma Ltd stock?

The Earnings Per Share (EPS) of Mankind Pharma Ltd is 48.13. An EPS is the amount of net income attributed to each share of a common stock.

How is Mankind Pharma Ltd EPS calculated?

The EPS of Mankind Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Mankind Pharma Ltd report its EPS?

Mankind Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Mankind Pharma Ltd EPS?

Factors that influence the EPS of Mankind Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Mankind Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Mankind Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions